Search for Clinical Trial Results
Mucopolysaccharidosis Type VI - 35 Studies Found
Status | Study |
Terminated |
Study Name: Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism Condition:
|
Recruiting |
Study Name: Human Placental-Derived Stem Cell Transplantation Condition:
Interventions: Drug: Human Placental Derived Stem Cell Infusions of thawed HPDSC to be given following UCB infusion. |
Recruiting |
Study Name: MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis Condition:
|
Active, not recruiting |
Study Name: Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders Condition:
Date: 2010-01-05 Interventions: |
Terminated |
Study Name: ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases Condition:
|
Completed |
Study Name: An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With MPS 7 Condition: Mucopolysaccharidosis Type 7 Date: 2013-05-08 Interventions: Drug: UX003 |
No longer available |
Study Name: An Open-Label Treatment Protocol With UX003 rhGUS Enzyme Replacement Therapy for an Advanced Stage MPS 7 Patient Condition: Mucopolysaccharidosis Type 7 Date: 2014-03-24 Interventions: Drug: UX003 Open Label Other Names: |
Recruiting |
Study Name: Biomarker for Sly Disease Condition:
|
Completed |
Study Name: A Phase 3 Study of UX003 rhGUS Enzyme Replacement Therapy in Patients With MPS 7 Condition:
Interventions: |
Active, not recruiting |
Study Name: A Long-Term Open-Label Treatment and Extension Study of UX003 rhGUS Enzyme Replacement Therapy in Subjects With MPS 7 Condition:
Interventions: Drug: UX003 UX003 is a sterile liquid buffered saline formulation of rhGUS that contains enzyme at a con |